These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

507 related items for PubMed ID: 16925769

  • 1. Different vascular endothelial growth factor (VEGF), VEGF-receptor 1 and -2 mRNA expression profiles between clear cell and papillary renal cell carcinoma.
    Ljungberg BJ, Jacobsen J, Rudolfsson SH, Lindh G, Grankvist K, Rasmuson T.
    BJU Int; 2006 Sep; 98(3):661-7. PubMed ID: 16925769
    [Abstract] [Full Text] [Related]

  • 2. Different isoform patterns for vascular endothelial growth factor between clear cell and papillary renal cell carcinoma.
    Jacobsen J, Grankvist K, Rasmuson T, Ljungberg B.
    BJU Int; 2006 May; 97(5):1102-8. PubMed ID: 16643499
    [Abstract] [Full Text] [Related]

  • 3. Hypoxia-inducible factor-2alpha mRNA expression in human renal cell carcinoma.
    Sandlund J, Ljungberg B, Wikström P, Grankvist K, Lindh G, Rasmuson T.
    Acta Oncol; 2009 May; 48(6):909-14. PubMed ID: 19322701
    [Abstract] [Full Text] [Related]

  • 4. Prognostic value of the expression of Ki-67, CD44 and vascular endothelial growth factor, and microvessel invasion, in renal cell carcinoma.
    Yildiz E, Gokce G, Kilicarslan H, Ayan S, Goze OF, Gultekin EY.
    BJU Int; 2004 May; 93(7):1087-93. PubMed ID: 15142169
    [Abstract] [Full Text] [Related]

  • 5. Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival.
    Decaussin M, Sartelet H, Robert C, Moro D, Claraz C, Brambilla C, Brambilla E.
    J Pathol; 1999 Aug; 188(4):369-77. PubMed ID: 10440746
    [Abstract] [Full Text] [Related]

  • 6. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V, Currie MJ, Gunningham SP, Morrin HR, Scott PA, Robinson BA, Fox SB.
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [Abstract] [Full Text] [Related]

  • 7. High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT-PCR mRNA expression profile.
    Baldewijns MM, Thijssen VL, Van den Eynden GG, Van Laere SJ, Bluekens AM, Roskams T, van Poppel H, De Bruïne AP, Griffioen AW, Vermeulen PB.
    Br J Cancer; 2007 Jun 18; 96(12):1888-95. PubMed ID: 17505508
    [Abstract] [Full Text] [Related]

  • 8. A phase II study of razoxane, an antiangiogenic topoisomerase II inhibitor, in renal cell cancer with assessment of potential surrogate markers of angiogenesis.
    Braybrooke JP, O'Byrne KJ, Propper DJ, Blann A, Saunders M, Dobbs N, Han C, Woodhull J, Mitchell K, Crew J, Smith K, Stephens R, Ganesan TS, Talbot DC, Harris AL.
    Clin Cancer Res; 2000 Dec 18; 6(12):4697-704. PubMed ID: 11156222
    [Abstract] [Full Text] [Related]

  • 9. VEGF and VEGFR-1 are coexpressed by epithelial and stromal cells of renal cell carcinoma.
    Rivet J, Mourah S, Murata H, Mounier N, Pisonero H, Mongiat-Artus P, Teillac P, Calvo F, Janin A, Dosquet C.
    Cancer; 2008 Jan 15; 112(2):433-42. PubMed ID: 18041056
    [Abstract] [Full Text] [Related]

  • 10. Vascular endothelial growth factor receptor expression as a prognostic marker for survival in colorectal cancer.
    Okita NT, Yamada Y, Takahari D, Hirashima Y, Matsubara J, Kato K, Hamaguchi T, Shirao K, Shimada Y, Taniguchi H, Shimoda T.
    Jpn J Clin Oncol; 2009 Sep 15; 39(9):595-600. PubMed ID: 19535387
    [Abstract] [Full Text] [Related]

  • 11. Vascular endothelial growth factor as prognostic factor in renal cell carcinoma.
    Jacobsen J, Rasmuson T, Grankvist K, Ljungberg B.
    J Urol; 2000 Jan 15; 163(1):343-7. PubMed ID: 10604387
    [Abstract] [Full Text] [Related]

  • 12. Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancer.
    Carrillo de Santa Pau E, Arias FC, Caso Peláez E, Muñoz Molina GM, Sánchez Hernández I, Muguruza Trueba I, Moreno Balsalobre R, Sacristán López S, Gómez Pinillos A, del Val Toledo Lobo M.
    Cancer; 2009 Apr 15; 115(8):1701-12. PubMed ID: 19197998
    [Abstract] [Full Text] [Related]

  • 13. Angiogenesis and other markers for prediction of survival in metastatic renal cell carcinoma.
    Alamdari FI, Rasmuson T, Grankvist K, Ljungberg B.
    Scand J Urol Nephrol; 2007 Apr 15; 41(1):5-9. PubMed ID: 17366095
    [Abstract] [Full Text] [Related]

  • 14. Comparative analysis of COX-2, vascular endothelial growth factor and microvessel density in human renal cell carcinomas.
    Hemmerlein B, Galuschka L, Putzer N, Zischkau S, Heuser M.
    Histopathology; 2004 Dec 15; 45(6):603-11. PubMed ID: 15569051
    [Abstract] [Full Text] [Related]

  • 15. [Expression and clinical significance of vascular endothelial growth factor and its receptors in multiple myeloma].
    Liu JR, Luo SK, Li J, Su C.
    Ai Zheng; 2007 Jun 15; 26(6):652-6. PubMed ID: 17562275
    [Abstract] [Full Text] [Related]

  • 16. Plasma level and tissue expression of vascular endothelial growth factor in renal cell carcinoma: a prospective study of 50 cases.
    Rioux-Leclercq N, Fergelot P, Zerrouki S, Leray E, Jouan F, Bellaud P, Epstein JI, Patard JJ.
    Hum Pathol; 2007 Oct 15; 38(10):1489-95. PubMed ID: 17597181
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Levels of angiogenesis and expression of angiogenesis-related genes are prognostic for organ-specific metastasis of renal cell carcinoma.
    Fukata S, Inoue K, Kamada M, Kawada C, Furihata M, Ohtsuki Y, Shuin T.
    Cancer; 2005 Mar 01; 103(5):931-42. PubMed ID: 15685621
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Lymphangiogenesis in kidney cancer: expression of VEGF-C, VEGF-D and VEGFR-3 in clear cell and papillary renal cell carcinoma.
    Bierer S, Herrmann E, Köpke T, Neumann J, Eltze E, Hertle L, Wülfing C.
    Oncol Rep; 2008 Oct 01; 20(4):721-5. PubMed ID: 18813809
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.